Saturday, 4th July 2009.

Posted on Friday, 5th June 2009 by dcooley

The Government rested on May 27, 2009 in the AffPower Internet pharmacy case, unique for its longevity as well as the attempted prosecution of online pharmacy affiliates along with the traditional players.  A general review of the respective Motions for Judgment of Acquittal by many of the Defendants indicates that the Government, among other things, neglected to call any witness to identify that the drugs (both controlled and non-controlled substances) identified in the indictment were actually the drugs received by the patients/customers of the Internet pharmacy. 

Additionally, the doctors who testified only testified about their general course of practice and not what their course of practice was with regards to the specific patient/customers identified in the indictment.  Intuitively, the doctors must be somewhat specific for a jury to find that the drugs were distributed without a legitimate medical purpose and not in the usual course of professional practice (as a reminder, this is a pre Ryan Haight Act prosecution).

I will review these in greater detail this weekend, but I wanted to provide a status update to those that have inquired about the status of the AffPower trial.

The content on this post does not constitute legal advice and is for informational purposes only.  You should not act upon the information presented on this website without seeking the advice of legal counsel.  Should you wish to speak to an experienced criminal defense lawyer knowledgeable in prescription, drug and internet pharmacy law, including the Controlled Substances Act, the Ryan Haight Act amendment and Federal Food, Drug and Cosmetic Act violations, please feel free to contact me directly.

 

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Tags: , , , , , ,
Posted in Court Cases | Comments (0)

Posted on Wednesday, 3rd June 2009 by dcooley

Torino Jennings, a Virgnia doctor, faces Internet pharmacy charges in a Boston District Court.  A felony Information was filed on May 28, 2009 charging Jennings with seven (7) counts of allegedly introducing a misbranded drug into interstate commerce in violation of the Federal Food, Drug and Cosmetic Act and four (4) counts of tax fraud for allegedly not reporting his online pharmacy income.  Specifically, the Information alleges that Jennings issued between 50,000 and 100,000 prescriptions of Soma and other drugs between 2004 and 2007 and received between $5.00 and $7.00 per prescription.  Furthermore, the Information alleges that virtually no request was rejected by Jennings.  While the Information alleges that Jennings prescribed other drugs besides Soma, Jennings is only charged with issuing seven Soma prescriptions to an individual identified as “E.D.”

Soma is a federal non-controlled substance; consequently, Jennings is charged under the Federal Food, Drug and Cosmetic Act (”FFDCA”) rather than the Controlled Substances Act and Ryan Haight Act amendment.  I have previously written extensively on non-controlled subtance internet pharmacy law issues associated with the FFDCA here.  As a brief summary, the FFDCA outlaws the misbranding of drugs.  A number of different actions qualify as misbranding, including the issuance of a prescription drug without a prescription.  Like many FFDCA cases, the Information in this case mistakenly states that “a prescription drug was misbranded when it is not dispensed pursuant to a valid prescription.”

Simply put, the FFDCA does not use the word valid.  Admittedly, it is up to a court to decide whether this is mere surplusage.  I question whether it is, however, given that the FFDCA uses the phrase “valid prescription” on other occasions in the same statute.  As a criminal defense attorney, I would be salivating at the opportunity to file a Motion to Dismiss in this case.

The content on this post does not constitute legal advice and is for informational purposes only.  You should not act upon the information presented on this website without seeking the advice of legal counsel.  Should you wish to speak to an experienced criminal defense lawyer knowledgeable in prescription, drug and internet pharmacy law, including the Controlled Substances Act, the Ryan Haight Act amendment and Federal Food, Drug and Cosmetic Act violations, please feel free to contact me directly.

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Tags: , , , , , , ,
Posted in Court Cases | Comments (0)

Posted on Saturday, 16th May 2009 by dcooley

Kansas pharmacist, Rick Kloxin, pled no contest to 14 misdemeanor counts in the Hogan’s Pharmacy internet pharmacy case.  Kloxin was the lead pharmacist at Hogan’s Pharmacy and plans to cooperate in the prosecution of Jolane and Mark Poindexter, the owners of Hogan’s.  In March, Kloxin lost his license and was fined $62,000.  A discussion of the administrative opinion can be found here.  As a reminder, the issues discussed at the Kansas administrative hearing parallel many of the federal Internet pharmacy law criminal defense issues (i.e. the Ryan Haight Act) analyzed on this website.

The Poindexter’s preliminary hearing began last Thursday in Lyons, Kansas.  They are charged under Kansas state law with operating an online questionnaire based Internet pharmacy.

The content on this post does not constitute legal advice and is for informational purposes only.  You should not act upon the information presented on this website without seeking the advice of legal counsel.  Should you wish to speak to an experienced criminal defense lawyer knowledgeable in prescription, drug and internet pharmacy law, including the Controlled Substances Act, the Ryan Haight Act amendment and Federal Food, Drug and Cosmetic Act violations, please feel free to contact me directly.

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Tags: , , , , , , ,
Posted in Court Cases | Comments (0)

Posted on Sunday, 10th May 2009 by dcooley

Many federal circuits permit a good faith jury instruction in cases in which doctors are prosecuted under the Controlled Substances Act.  Internet pharmacy law cases involving doctors are no different.  Below is an illustrative case:

U.S. v. Hurwitz, 459 F.3d 463 (2006):  The Fourth Circuit Court of Appeals reversed Dr. William E. Hurtwitz’s conviction due to the trial court’s failure to instruct the jury on objective ”good faith.”  Hurwitz was convicted of one count of conspiracy, one count of drug trafficking resulting in death, two counts of drug trafficking resulting in serious bodily injury, and forty-six counts of drug trafficking.  The jury acquitted Hurtwitz on one count of engaging in a continuing criminal enterprise and two counts of health care fraud.

The evidence at trial suggested that a number of Hurtwitz’s patients were arrested for selling prescription drugs.  After identifying Hurtwitz as their source, investigators learned that Hurtwitz was prescribing extraordinarily high doses of opioids to his patients:

Hurtwitz often wrote prescriptions calling for a patient to take thirty 80-milligram Oxycontins per day.  For Hurtwitz’s patients in the high-dose program, a prescribed opioid dosage of 100 pills per day was not uncommon . . . Between July 1999 and October 2002, Hurwitz prescribed to one patient a total of more than 200,000 pills, which amounted to more than 400 pills per day . . . Patients with limited sources of income spent tens of thousands of dollars on narcotics prescribed by Hurtwitz.

Hurwitz argued that he was not a pill-pusher.  He required patients to fill out medical questionnaires and submit medical records.  Hurwitz also actively conferenced with other professionals with regards to the treatment of pain.  Additionally, the defense argued that the high-dose protocol was appropriate medical practice “for treating patients with intractable pain.”  Because the body quickly develops resistance to opioids, high doses become necessary to have any effect whatsoever.

The appellate court reversed Dr. Hurwitz’s conviction, because the trial court erred in failing to instruct the jury on “good faith.”  The Code of Federal Regulations states that a controlled substance prescription is effective only if it is “issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.”  The Appellate Court found that “a doctor’s good faith generally is relevant to a jury’s determination of whether the doctor acted outside the bounds of medical practice or without a legitimate medical purpose when prescribing narcotics.”  “Some latitude must be given to doctors trying to determine the current boundaries of acceptable medical practice.  Thus, courts have consistently concluded that it is proper to instruct juries that a doctor should not be held criminally liable if the doctor acted in good faith when treating his patients.”

In Internet pharmacy law prosecutions involving doctors, criminal defense attorneys should push for a good faith jury instruction.  The failure to instruct the jury on good faith was not harmless error in U.S. v. Hurwtiz.  It was important enough to require reversal, even in the light of arguably overwhelming evidence of guilt.  Thus, in many circuits, obtaining such instruction is a very realistic possibility.

Keep in mind that a good faith instruction is relevant even in post-Ryan Haight Act prosecutions.  Note that even though the Ryan Haight Act requires face to face medical examinations, the fact that a face to face examination is conducted is not per se compliance with the Controlled Substances Act.  The DEA Rule implementing the Ryan Haight Act specifically states that a court must still analyze whether the facts of each case suggest that the prescription was issued for a legitimate medical purpose and in the usual course of professional practice:

At the same time, it is crucial to bear in mind that, as Congress expressly stated under the Act, the mere fact that the prescribing practitioner conducted one in-person medical evaluation does not demonstrate that the prescription was issued for a legitimate medical purpose within the usual course of professional practice.  Even where the prescribing practitioner has complied with the requirement of at least one in-person medical evaluation, a prescription for a controlled substance must still satisfy the additional, fundamental prerequisite that has been legally mandated for more than 90 years:  it must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice.

Consequently, criminal defense lawyers should still request a good faith instruction even in criminal cases originating from post-Ryan Haight Act offenses.

Moreover, I would argue that a good faith instruction is required even in federal criminal cases in which the doctor is not indicted or prosecuted.  When a doctor involved in an online pharmacy operation is not indicted, the doctor’s good faith is still relevant.  For example, assume that the players in an online consultation service internet pharmacy are indicted, including the website owner and pharmacist.  However, for some reason or another, assume the doctor was not indicted.  I would still argue that the jury must be instructed on a doctor’s good faith.  Because the website owner or pharmacist can only be prosecuted if the prescription was invalid (i.e. it was issued by a doctor without a legitimate medical purpose or not in the course of a professional practice), the doctor’s good faith is still a relevant inquiry.  In other words, whether the pharmacist or website owner is guilty is largely dependant on the customer’s interaction with the physician.  If the prescription was objectively issued in good faith by a physician, then the pharmacist or website owner should not be convicted.

The content on this post does not constitute legal advice and is for informational purposes only.  You should not act upon the information presented on this website without seeking the advice of legal counsel.  Should you wish to speak to an experienced criminal defense lawyer knowledgeable in prescription, drug and Internet pharmacy law, including the Controlled Substances Act, the Ryan Haight Act and Federal Food, Drug and Cosmetic Act violations, please feel free to contact me directly.

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Tags: , , , , , , , ,
Posted in Court Cases, Doctors, Pharmacies, Ryan Haight Act, Website Owners | Comments (0)

Posted on Thursday, 30th April 2009 by dcooley

According to the Orlando Sentential and the Daytona Beach News-Journal, JIVE internet pharmacy owner Jude Lacour was found guilty on all counts today, including conspiracy, distribution of a controlled substance and money laundering.  Lacour represented himself at trial.  Christopher Tobin was also found guilty on all counts charged.  The other defendants (Akhil Baranwal, James Pickens and Geunnet Chebssi) were each found guilty on at least one count and not guilty on another.

The content on this post does not constitute legal advice and is for informational purposes only.  You should not act upon the information presented on this website without seeking the advice of legal counsel.  Should you wish to speak to an experienced criminal defense lawyer knowledgeable in prescription, drug and Internet pharmacy law, including the Controlled Substances Act, the Ryan Haight Act and Federal Food, Drug and Cosmetic Act violations, please feel free to contact me directly.

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Tags: , , ,
Posted in Court Cases | Comments (0)

Posted on Wednesday, 29th April 2009 by dcooley

The jury began deliberating in the JIVE online pharmacy network trial yesterday at 3p.m.

The content on this post does not constitute legal advice and is for informational purposes only.  You should not act upon the information presented on this website without seeking the advice of legal counsel.  Should you wish to speak to an experienced criminal defense lawyer knowledgeable in prescription, drug and Internet pharmacy law, including the Controlled Substances Act, the Ryan Haight Act and Federal Food, Drug and Cosmetic Act violations, please feel free to contact me directly.

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Tags: , ,
Posted in Court Cases | Comments (0)

About Legal Services Attorney Profile and Contact Information Legal Disclaimer